| Trial ID: | L6285 |
| Source ID: | NCT00642915
|
| Associated Drug: |
Lantus, Amaryl
|
| Title: |
Insulin Glargine Benefits in Japanese Pts Outside of Japan (US or Brazil)
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus
|
| Interventions: |
DRUG: Lantus, Amaryl
|
| Outcome Measures: |
Primary: Estimate the efficacy of combination therapy with Lantus plus Amarylin controlling blood glucose in Japanese patients with type 2 diabetes having failed oral antidiabetic drug therapy, Hemoglobin A1c values were measured at Screening and at every visit thereafter. | Secondary: Document the ability to preserve the endocrine pancreatic function with Lantus plus Amaryl combination therapy, 24 weeks
|
| Sponsor/Collaborators: |
Sponsor: Sanofi
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
100
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2003-06
|
| Completion Date: |
2004-07
|
| Results First Posted: |
|
| Last Update Posted: |
2008-08-25
|
| Locations: |
Sanofi-Aventis, Sao Paulo, Brazil
|
| URL: |
https://clinicaltrials.gov/show/NCT00642915
|
